Piritramide is under investigation for the treatment of Colon Cancer and Minimal Residual Disease. Piritramide has been investigated for the supportive care of Pain, Postoperative and Postoperative Nausea and Vomiting.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Piritramide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Piritramide. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Piritramide. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Piritramide. |
| Hydrocodone | Piritramide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Piritramide. |
| Magnesium sulfate | The therapeutic efficacy of Piritramide can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Piritramide may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Piritramide may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Piritramide. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Piritramide. |
| Orphenadrine | Piritramide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Piritramide may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Piritramide. |
| Pramipexole | Piritramide may increase the sedative activities of Pramipexole. |
| Ropinirole | Piritramide may increase the sedative activities of Ropinirole. |
| Rotigotine | Piritramide may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Piritramide. |
| Sodium oxybate | The risk or severity of CNS depression can be increased when Sodium oxybate is combined with Piritramide. |
| Suvorexant | Piritramide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Piritramide. |
| Thalidomide | Piritramide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Piritramide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Alvimopan | The risk or severity of adverse effects can be increased when Piritramide is combined with Alvimopan. |
| Desmopressin | The risk or severity of hyponatremia can be increased when Piritramide is combined with Desmopressin. |
| Morphine | The risk or severity of adverse effects can be increased when Morphine is combined with Piritramide. |
| Codeine | The risk or severity of adverse effects can be increased when Codeine is combined with Piritramide. |
| Hydromorphone | The risk or severity of adverse effects can be increased when Hydromorphone is combined with Piritramide. |
| Meperidine | The risk or severity of adverse effects can be increased when Meperidine is combined with Piritramide. |
| Oxycodone | The risk or severity of adverse effects can be increased when Oxycodone is combined with Piritramide. |
| Dextropropoxyphene | The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Piritramide. |
| Naltrexone | The therapeutic efficacy of Piritramide can be decreased when used in combination with Naltrexone. |
| Sufentanil | The risk or severity of adverse effects can be increased when Sufentanil is combined with Piritramide. |
| Alfentanil | The risk or severity of adverse effects can be increased when Alfentanil is combined with Piritramide. |
| Fentanyl | The risk or severity of adverse effects can be increased when Fentanyl is combined with Piritramide. |
| Levorphanol | The risk or severity of adverse effects can be increased when Levorphanol is combined with Piritramide. |
| Remifentanil | The risk or severity of adverse effects can be increased when Remifentanil is combined with Piritramide. |
| Diphenoxylate | The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Piritramide. |
| Oxymorphone | The risk or severity of adverse effects can be increased when Oxymorphone is combined with Piritramide. |
| Dezocine | The risk or severity of adverse effects can be increased when Dezocine is combined with Piritramide. |
| Methadyl acetate | The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Piritramide. |
| Dihydroetorphine | The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Piritramide. |
| Diamorphine | The risk or severity of adverse effects can be increased when Diamorphine is combined with Piritramide. |
| Bezitramide | The risk or severity of adverse effects can be increased when Bezitramide is combined with Piritramide. |
| Ethylmorphine | The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Piritramide. |
| Etorphine | The risk or severity of adverse effects can be increased when Etorphine is combined with Piritramide. |
| Dextromoramide | The risk or severity of adverse effects can be increased when Dextromoramide is combined with Piritramide. |
| Desomorphine | The risk or severity of adverse effects can be increased when Desomorphine is combined with Piritramide. |
| Carfentanil | The risk or severity of adverse effects can be increased when Carfentanil is combined with Piritramide. |
| Dihydrocodeine | The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Piritramide. |
| Alphacetylmethadol | The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Piritramide. |
| Dihydromorphine | The risk or severity of adverse effects can be increased when Dihydromorphine is combined with Piritramide. |
| Ketobemidone | The risk or severity of adverse effects can be increased when Ketobemidone is combined with Piritramide. |
| DPDPE | The risk or severity of adverse effects can be increased when DPDPE is combined with Piritramide. |
| Lofentanil | The risk or severity of adverse effects can be increased when Lofentanil is combined with Piritramide. |
| Opium | The risk or severity of adverse effects can be increased when Opium is combined with Piritramide. |
| Normethadone | The risk or severity of adverse effects can be increased when Normethadone is combined with Piritramide. |
| Alphaprodine | The risk or severity of adverse effects can be increased when Piritramide is combined with Alphaprodine. |
| Nicomorphine | The risk or severity of adverse effects can be increased when Piritramide is combined with Nicomorphine. |
| Meptazinol | The therapeutic efficacy of Piritramide can be decreased when used in combination with Meptazinol. |
| Phenoperidine | The risk or severity of adverse effects can be increased when Piritramide is combined with Phenoperidine. |
| Phenazocine | The risk or severity of adverse effects can be increased when Piritramide is combined with Phenazocine. |
| Tilidine | The risk or severity of adverse effects can be increased when Piritramide is combined with Tilidine. |
| Carfentanil, C-11 | The risk or severity of adverse effects can be increased when Piritramide is combined with Carfentanil, C-11. |
| Naloxegol | The risk or severity of adverse effects can be increased when Naloxegol is combined with Piritramide. |
| Benzhydrocodone | The risk or severity of adverse effects can be increased when Piritramide is combined with Benzhydrocodone. |
| Pegvisomant | The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Piritramide. |
| Succinylcholine | The risk or severity of bradycardia can be increased when Succinylcholine is combined with Piritramide. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Piritramide. |
| Linezolid | The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Piritramide. |
| Mirtazapine | Piritramide may increase the serotonergic activities of Mirtazapine. |
| Fluvoxamine | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Fluvoxamine. |
| Citalopram | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Citalopram. |
| Duloxetine | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Duloxetine. |
| Paroxetine | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Paroxetine. |
| Sertraline | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Sertraline. |
| Sibutramine | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Sibutramine. |
| Nefazodone | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Nefazodone. |
| Zimelidine | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Zimelidine. |
| Dapoxetine | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Dapoxetine. |
| Milnacipran | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Piritramide. |
| Seproxetine | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Seproxetine. |
| Levomilnacipran | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Levomilnacipran. |
| Indalpine | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Indalpine. |
| Ritanserin | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Ritanserin. |
| Alaproclate | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Alaproclate. |
| Ethanol | Piritramide may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Piritramide may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Piritramide. |
| Phentermine | Phentermine may increase the analgesic activities of Piritramide. |
| Pseudoephedrine | Pseudoephedrine may increase the analgesic activities of Piritramide. |
| Benzphetamine | Benzphetamine may increase the analgesic activities of Piritramide. |
| Diethylpropion | Diethylpropion may increase the analgesic activities of Piritramide. |
| Lisdexamfetamine | The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Lisdexamfetamine. |
| Mephentermine | Mephentermine may increase the analgesic activities of Piritramide. |
| MMDA | MMDA may increase the analgesic activities of Piritramide. |
| Midomafetamine | Midomafetamine may increase the analgesic activities of Piritramide. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may increase the analgesic activities of Piritramide. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may increase the analgesic activities of Piritramide. |